TrialSleep & breathing = Schlaf & Atmung2022

Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson's disease.

Mario Meloni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.